These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11332992

  • 1. Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs.
    Märten A, Ziske C, Schöttker B, Weineck S, Renoth S, Buttgereit P, Schakowski F, König S, von Rücker A, Allera A, Schroers R, Sauerbruch T, Wittig B, Schmidt-Wolf IG.
    Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992
    [Abstract] [Full Text] [Related]

  • 2. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
    Meissner M, Whiteside TL, Kaufmann R, Seliger B.
    Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.
    J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831
    [Abstract] [Full Text] [Related]

  • 5. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.
    LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W.
    Nat Immunol; 2004 Sep 15; 5(9):899-908. PubMed ID: 15322541
    [Abstract] [Full Text] [Related]

  • 6. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
    Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N.
    Glia; 2004 Mar 15; 45(4):392-405. PubMed ID: 14966870
    [Abstract] [Full Text] [Related]

  • 7. Combination gene therapy with CD86 and the MHC class II transactivator in the control of lung tumor growth.
    Martin BK, Frelinger JG, Ting JP.
    J Immunol; 1999 Jun 01; 162(11):6663-70. PubMed ID: 10352284
    [Abstract] [Full Text] [Related]

  • 8. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V, Otten LA, Zufferey M, Mach B.
    Cell; 1993 Oct 08; 75(1):135-46. PubMed ID: 8402893
    [Abstract] [Full Text] [Related]

  • 9. Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells.
    Meazza R, Comes A, Orengo AM, Ferrini S, Accolla RS.
    Eur J Immunol; 2003 May 08; 33(5):1183-92. PubMed ID: 12731043
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 11. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 25; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 12. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
    Kitamura N, Yokoyama H, Yashiro T, Nakano N, Nishiyama M, Kanada S, Fukai T, Hara M, Ikeda S, Ogawa H, Okumura K, Nishiyama C.
    J Allergy Clin Immunol; 2012 Mar 25; 129(3):814-824.e6. PubMed ID: 22112519
    [Abstract] [Full Text] [Related]

  • 13. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
    Thompson JA, Dissanayake SK, Ksander BR, Knutson KL, Disis ML, Ostrand-Rosenberg S.
    Cancer Res; 2006 Jan 15; 66(2):1147-54. PubMed ID: 16424052
    [Abstract] [Full Text] [Related]

  • 14. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 15. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE, Yu HN, Yoon CH, Bae YS.
    Eur J Immunol; 2009 Mar 27; 39(3):858-68. PubMed ID: 19224634
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M, Jager M, Ono SJ.
    Exp Mol Pathol; 2007 Feb 27; 82(1):68-76. PubMed ID: 16650406
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
    Tan G, Wang ZY, Yin S.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 11; 86(14):943-6. PubMed ID: 16759530
    [Abstract] [Full Text] [Related]

  • 18. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G.
    Cell Growth Differ; 2001 Jun 11; 12(6):327-35. PubMed ID: 11432807
    [Abstract] [Full Text] [Related]

  • 19. [Construction of mutants of MHC class II molecule transactivator gene capable of suppressing HLA-DR/DQ expression and exploration on their mechanism].
    Ou QS, Lin L, Huang LD, Lu PH, Zhou GY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep 11; 19(5):417-20. PubMed ID: 15169643
    [Abstract] [Full Text] [Related]

  • 20. [Cloning and biological activities of riboenzymes against major histocompatibility complex class II transactivator].
    Guo R, Zou P, Yang XC, Lu HZ, Gao F, Cao YL, Zhang M, Fan HH.
    Zhonghua Yi Xue Za Zhi; 2003 Apr 25; 83(8):669-72. PubMed ID: 12887826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.